COVID-19 vaccines may not work as well against South African variant, experts worry – Livescience.com
A coronavirus variant identified in South Africa may not be as vulnerable to COVID-19 vaccines as other strains, some scientists say.
Studies are now underway to find out if that's actually the case.
If the variant, known as 501.V2, is resistant to available vaccines, the shots could be tweaked to boost their effectiveness — adjustments tht would take about six weeks to make, vaccine developers told Reuters. These developers included BioNTech CEO Dr. Uğur Şahin and John Bell, Regius Professor of Medicine at the University of Oxford, who are currently running experiments with both 501.V2 and the new coronavirus variant identified in the U.K., named B.1.1.7.
These experiments are so-called neutralizing assays — experiments in which they incubate the viruses with antibodies and human ...